✦ LIBER ✦

2007 4 WEEK THERAPY WITH THE NON-NUCLEOSIDIC POLYMERASE INHIBITOR BI207127 IN COMBINATION WITH PEGINTERFERON-ALFA2A AND RIBAVIRIN IN TREATMENT NAIVE AND TREATMENT EXPERIENCED CHRONIC HCV GT1 PATIENTS

✍ Scribed by Larrey, D.; Lohse, A.; de Ledinghen, V.; Trepo, C.; Gerlach, T.; Zarski, J.-P.; Tran, A.; Mathurin, P.; Thimme, R.; Arastéh, K.; Trautwein, C.; Cerny, A.; Dikopoulos, N.; Schuchmann, M.; Heim, M.H.; Gerken, G.; Stern, J.; Wu, K.; Abdallah, N.; Girlich, B.; Josepf, S.; Wulf, B.; Berger, F.; Steffgen, J.

Book ID: 123307505
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 54 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(10)61198-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid and strong antiviral activity of t

Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin

✍ Dominique Larrey; Ansgar W. Lohse; Victor de Ledinghen; Christian Trepo; Tilman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 857 KB

290 EARLY VIROLOGICAL RESPONSE PROFILES

290 EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR

✍ F. Poordad; J.G. McHutchison; M.L. Shiffman; T. Berg; A.J. Muir; M.P. Manns; A.M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 188 KB

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS

✍ Christensen, S.; Mauss, S.; Eisenbach, C.; Jung, M.-C.; Roessle, M.; Emke, F.; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONS

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

✍ M.S. Sulkowski; E. Ceasu; T. Asselah; F.A. Caruntu; J. Lalezari; P. Ferenci; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

311 Longer treatment duration with pegin

311 Longer treatment duration with peginterferon alfa-2A (40KD) (Pegasys®) and ribavirin (Copegus®) in naive patients with chronic hepatitis C and detectable HCV RNA by week 4 of therapy: Preliminary results of the teravic-4 study

✍ J.M. Sánchez-Tapias; M. Diago; P. Escartin; J. Enriquez; R. Moreno; H. La Prince 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

1163 A PHASE 2A STUDY OF BMS-791325, AN

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

✍ Tatum, H.; Thuluvath, P.; Lawitz, E.; Martorell, C.T.; Demicco, M.; Cohen, S.; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB